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An imbalance in protein production is common to
several diseases. Endoplasmic reticulum (ER) stress
occurs when proteins misfold during biosynthesis,
resulting in reduced production of cell surface
and secreted proteins. Misfolding activates cellular
stress pathways including the unfolded protein
response (UPR), the production of reactive oxygen
and nitrogen species and a state of oxidative
stress. Oxidative stress and ER stress are integrally
entwined states, implicated in the aetiology of
many diseases, diabetes and obesity1, arthritis and
spondyloarthropathies, multiple forms of
respiratory inflammation2, inflammatory bowel
diseases, infections3 and cancer4. Consequently,
there is substantial interest in therapeutic
targeting of stress in a variety of disorders.
Major intracellular stress response pathways
triggered by oxidative stress and ER stress (UPR) in
turn regulate inflammatory pathways. Oxidative
stress results from an imbalance between oxidants
[reactive oxygen species (ROS) and reactive
nitrogen species (RNS)] derived from the local
environment or produced within cells and cellular
antioxidants. Protein folding in the ER results in
production of ROS, which are deactivated by
endogenous antioxidants such as glutathione
peroxidase and superoxide dismutase. Despite ER-
resident chaperones and enzymes that promote
correct protein folding, a proportion of all
proteins misfold. Factors known to increase
misfolding include ROS and RNS, increased
protein synthesis, microbial toxins, viral infection
and cytokines. Prolonged or severe ER stress can
induce inflammation, autophagy and apoptosis
(Figure 1). The mechanisms by which ER stress
influences pathology, and is interlinked with
inflammation and oxidative stress, are covered by
the reviews in this Special Feature of Clinical &
Translational Immunology.
Our understanding of the crosstalk between
different cellular stress pathways and
inflammation is constantly evolving. Pickering
et al.1 describe the increase in hyperglycaemia-
induced ROS is associated with increased low-
grade chronic inflammation resulting in diabetic
complications such as cardiovascular disease,
chronic kidney disease and retinopathy. They raise
an interesting possibility of utilising anti-
inflammatory drugs that have dual effects – on
inflammation and on oxidative stress – and that
potentially a combination of the two might be an
approach to improve disease outcomes in diabetic
complications more effectively.1
Excessive production of monoclonal
immunoglobulin is a key feature of multiple
myeloma. Nikesitch et al.4 describe that this
increased protein production induces ER stress
and activates the proteosomal degradation
pathways to avoid accumulation of the protein in
the ER and the consequent cell death.
Proteosomal inhibitors have been quite effective,
but unfortunately, there is increased resistance to
therapies such as bortezomib. There is a need for
development of treatments that could include
autophagy inhibitors, heat-shock protein
inhibitors or ubiquitin ligase inhibitors. However,
resistance to such drugs might be a possibility;
therefore, drugs that could specifically target
resistance to proteasome inhibitors or resensitise
multiple myeloma to proteasome inhibitors
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should be developed. The mechanisms around
resistance and the exact involvement of the UPR
are unclear in multiple myeloma, and a better
understanding of the pathways is required prior
to the development of effective therapies.
Chen et al.2 discuss the influences of intrinsic
cell and environmental factors that have the
potential to contribute to oxidative stress and ER
stress in a range of respiratory diseases, including
cystic fibrosis, asthma and idiopathic pulmonary
fibrosis.2 Even though proof-of-concept studies in
animals show that blocking ER and oxidative
stress is effective in models of respiratory
inflammation, the use of antioxidants, in
particular N-acetyl-cysteine, in respiratory disease-
focussed clinical trials have been largely
disappointing. It is clear that ER and oxidative
stress are an integral part of exacerbating the
inflammation which leads to pathophysiology in
respiratory disease; however, there is a growing
need for specific inhibitors with reduced toxicity.
In order to replicate, viruses must utilise the
host ER. By selectively regulating parts of the UPR,
particularly elements that block translation, some
viruses have evolved mechanisms to manipulate
host stress responses in order to maintain viral
replication. Cytokines can modulate ER stress,
although the underlying purpose of this is still
unknown. Wang et al. 3 hypothesise that, despite
the ability of viruses to regulate the UPR, innate
cytokines are released quickly and dynamically to
either limit or disturb viral protein biosynthesis via
the induction of oxidative stress. Because ROS and
RNS directly cause proteins to misfold in the ER,
the viral inhibition of the UPR allowing
translation to proceed will be ineffective, as the
translated viral proteins will misfold as a result of
the inappropriate oxidative state in the ER.
Dysregulation of the cellular stress pathways can
contribute to pathology during viral infection and
chronic noninfectious inflammation, and
therefore, alleviating cellular stress has
therapeutic potential. One such cytokine that has
been shown to modulate the cellular stress
pathways is Interleukin-22 (IL-22). Alabbas et al.5
discuss the reported pro- and anti-inflammatory
roles of IL-22 and its role in modulating the
oxidative stress and ER stress response. The
Figure 1. Schematic representation of different factors that can induce ER stress, including reactive oxygen species, increased protein load within
the ER, microbial products, infections and cytokine. Acute ER stress response activates pathways to rectify the accumulation of misfolded
proteins. However, chronic activation of the ER stress pathways in disease can lead to inflammation, autophagy and apoptosis.
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potential use of IL-22 as therapy is dependent on
the timing of treatment, dosing and the
underlying disease pathology, for example IL-22 is
pro-inflammatory in psoriasis, whereas it is anti-
inflammatory in diabetes.
Together, the reviews in this Special Feature
highlight the need for understanding the complex
relationship between the cellular stress pathways
and inflammation. It is clear that ER stress and
inflammation are implicated in the pathophysiology
of several infectious and inflammatory diseases.
The ultimate aim of the research in the field is to
devise new strategies to alleviate or prevent
inflammatory diseases, and a deeper understanding
of these pathways may identify new and
complementary targets for therapies for a range of
chronic diseases.
CONFLICT OF INTEREST
The author declares no conflict of interest.
REFERENCES
1. Pickering RJ, Rosado CJ, Sharma A et al. Recent novel
approaches to limit oxidative stress and inflammation in
diabetic complications. Clin Transl Immunol 2018; 7: e1016.
2. Chen AC-H, Burr L, McGuckin MA. Oxidative and
endoplasmic reticulum stress in respiratory disease. Clin
Transl Immunol 2018; 7: e1019.
3. Wang R, Moniruzzaman MD, Shuffle E et al. Immune
regulation of the unfolded protein response at the
mucosal barrier in viral infection. Clin Transl Immunol
2018; 7: e1014.
4. Nikesitch N, Lee JM, Ling S et al. Endoplasmic reticulum
stress in the development of multiple myeloma and drug
resistance. Clin Transl Immunol 2018; 7: e1007.
5. Alabbas SY, Begun J, Florin TH et al. The role of IL-22 in
the resolution of sterile and nonsterile inflammation.
Clin Transl Immunol 2018; 7: e1017.
This is an open access article under the terms of the
Creative Commons Attribution-NonCommercial
License, which permits use, distribution and
reproduction in any medium, provided the original
work is properly cited and is not used for commercial
purposes.
ª 2018 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
Australasian Society for Immunology Inc.
2018 | Vol. 7 | e1035
Page 3
SZ Hasnain Editorial. Endoplasmic reticulum and oxidative stress in immunopathology
